Skip to main content
Erschienen in: Obesity Surgery 11/2018

25.07.2018 | Original Contributions

Update: 10 Years of Sleeve Gastrectomy—the First 103 Patients

verfasst von: Daniel M. Felsenreich, Lukas M. Ladinig, Philipp Beckerhinn, Christoph Sperker, Katrin Schwameis, Michael Krebs, Julia Jedamzik, Magdalena Eilenberg, Christoph Bichler, Gerhard Prager, Felix B. Langer

Erschienen in: Obesity Surgery | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Sleeve gastrectomy (SG) has been the most frequently performed bariatric procedure worldwide since 2014. Therefore, it is vital to look at its outcomes in a long-term follow-up based on a large patient collective. Main points of discussion are weight regain, reflux, and patients’ quality of life at 10+ years after the procedure.

Objectives

The aim of this study is to present an update of data that have been published recently and, thus, achieve more conclusive results. The number of patients has been doubled, and the length of the follow-up is still 10+ years.

Setting

Multi-center study, medical university clinic, Austria

Methods

This study includes all patients who had SG before December 2006 at the participating bariatric centers. At 10+ years, non-converted patients (67%) were examined using gastroscopy, manometry, 24-hour pH-metry, and questionnaires. Patients’ history of weight, comorbidities, and reflux were established through interviews.

Results

At 10+ years after SG, the authors found a conversion rate of 33%, an %EWL in non-converted patients of 50.0 ± 22.5, reflux in 57%, and Barrett’s metaplasia in 14% of non-converted patients. Gastroscopies revealed that patients with reflux were significantly more likely to have de-novo hiatal hernia. A significantly lower quality of life was detected through GIQLI and BAROS in patients with reflux.

Conclusion

The authors recommend gastroscopies at 5-year intervals after SG to detect the possible sequelae of reflux at an early stage. Conversion to Roux-en-Y-gastric bypass (RYGB) works well to cure patients from reflux but may not be as efficient at treating weight regain.
Literatur
1.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015.
2.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017.
3.
Zurück zum Zitat Aminian A, Andalib A, Khorgami Z, et al. A nationwide safety analysis of bariatric surgery in nonseverely obese patients with type 2 diabetes. Surg Obes Relat Dis. 2016;12(6):1163–70.CrossRefPubMed Aminian A, Andalib A, Khorgami Z, et al. A nationwide safety analysis of bariatric surgery in nonseverely obese patients with type 2 diabetes. Surg Obes Relat Dis. 2016;12(6):1163–70.CrossRefPubMed
4.
Zurück zum Zitat Alexandrou A, Felekouras E, Giannopoulos A, et al. What is the actual fate of super-morbid-obese patients who undergo laparoscopic sleeve gastrectomy as the first step of a two-stage weight-reduction operative strategy? Obes Surg. 2012;22(10):1623–8.CrossRefPubMed Alexandrou A, Felekouras E, Giannopoulos A, et al. What is the actual fate of super-morbid-obese patients who undergo laparoscopic sleeve gastrectomy as the first step of a two-stage weight-reduction operative strategy? Obes Surg. 2012;22(10):1623–8.CrossRefPubMed
5.
Zurück zum Zitat Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32.CrossRefPubMed Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32.CrossRefPubMed
6.
Zurück zum Zitat Felsenreich DM, Langer FB, Kefurt R, et al. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(9):1655–62.CrossRefPubMed Felsenreich DM, Langer FB, Kefurt R, et al. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(9):1655–62.CrossRefPubMed
7.
Zurück zum Zitat Moritz Felsenreich D, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017. Moritz Felsenreich D, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017.
8.
Zurück zum Zitat Kariv R, Plesec TP, Goldblum JR, et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol. 2009;7(6):653–8. quiz 06CrossRefPubMed Kariv R, Plesec TP, Goldblum JR, et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol. 2009;7(6):653–8. quiz 06CrossRefPubMed
9.
Zurück zum Zitat Arman GA, Himpens J, Dhaenens J, et al. Long-term (11+ years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(10):1778–86.CrossRefPubMed Arman GA, Himpens J, Dhaenens J, et al. Long-term (11+ years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(10):1778–86.CrossRefPubMed
10.
Zurück zum Zitat Mandeville Y, Van Looveren R, Vancoillie PJ, et al. Moderating the enthusiasm of sleeve gastrectomy: up to fifty percent of reflux symptoms after ten years in a consecutive series of one hundred laparoscopic sleeve gastrectomies. Obes Surg. 2017. Mandeville Y, Van Looveren R, Vancoillie PJ, et al. Moderating the enthusiasm of sleeve gastrectomy: up to fifty percent of reflux symptoms after ten years in a consecutive series of one hundred laparoscopic sleeve gastrectomies. Obes Surg. 2017.
11.
Zurück zum Zitat Parmar CD, Mahawar KK, Boyle M, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass is effective for gastro-oesophageal reflux disease but not for further weight loss. Obes Surg. 2017. Parmar CD, Mahawar KK, Boyle M, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass is effective for gastro-oesophageal reflux disease but not for further weight loss. Obes Surg. 2017.
12.
Zurück zum Zitat Casillas RA, Um SS, Zelada Getty JL, et al. Revision of primary sleeve gastrectomy to Roux-en-Y gastric bypass: indications and outcomes from a high-volume center. Surg Obes Relat Dis. 2016;12(10):1817–25.CrossRefPubMed Casillas RA, Um SS, Zelada Getty JL, et al. Revision of primary sleeve gastrectomy to Roux-en-Y gastric bypass: indications and outcomes from a high-volume center. Surg Obes Relat Dis. 2016;12(10):1817–25.CrossRefPubMed
13.
Zurück zum Zitat Malinka T, Zerkowski J, Katharina I, et al. Three-year outcomes of revisional laparoscopic gastric bypass after failed laparoscopic sleeve gastrectomy: a case-matched analysis. Obes Surg. 2017. Malinka T, Zerkowski J, Katharina I, et al. Three-year outcomes of revisional laparoscopic gastric bypass after failed laparoscopic sleeve gastrectomy: a case-matched analysis. Obes Surg. 2017.
14.
Zurück zum Zitat Yilmaz H, Ece I, Sahin M. Revisional surgery after failed laparoscopic sleeve gastrectomy: retrospective analysis of causes, results, and technical considerations. Obes Surg. 2017. Yilmaz H, Ece I, Sahin M. Revisional surgery after failed laparoscopic sleeve gastrectomy: retrospective analysis of causes, results, and technical considerations. Obes Surg. 2017.
15.
Zurück zum Zitat Noel P, Nedelcu M, Eddbali I, et al. What are the long-term results 8 years after sleeve gastrectomy? Surg Obes Relat Dis. 2017;13(7):1110–5.CrossRefPubMed Noel P, Nedelcu M, Eddbali I, et al. What are the long-term results 8 years after sleeve gastrectomy? Surg Obes Relat Dis. 2017;13(7):1110–5.CrossRefPubMed
16.
Zurück zum Zitat Sarela AI, Dexter SP, O’Kane M, et al. Long-term follow-up after laparoscopic sleeve gastrectomy: 8–9-year results. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery. 2012;8(6):679–84.CrossRef Sarela AI, Dexter SP, O’Kane M, et al. Long-term follow-up after laparoscopic sleeve gastrectomy: 8–9-year results. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery. 2012;8(6):679–84.CrossRef
17.
Zurück zum Zitat Tassinari D, Berta RD, Nannipieri M, et al. Sleeve gastrectomy: correlation of long-term results with remnant morphology and eating disorders. Obes Surg. 2017. Tassinari D, Berta RD, Nannipieri M, et al. Sleeve gastrectomy: correlation of long-term results with remnant morphology and eating disorders. Obes Surg. 2017.
18.
Zurück zum Zitat Ferrer-Marquez M, Garcia-Diaz JJ, Moreno-Serrano A, et al. Changes in gastric volume and their implications for weight loss after laparoscopic sleeve gastrectomy. Obes Surg. 2017;27(2):303–9.CrossRefPubMed Ferrer-Marquez M, Garcia-Diaz JJ, Moreno-Serrano A, et al. Changes in gastric volume and their implications for weight loss after laparoscopic sleeve gastrectomy. Obes Surg. 2017;27(2):303–9.CrossRefPubMed
19.
Zurück zum Zitat Yormaz S, Yilmaz H, Ece I, et al. Midterm clinical outcomes of antrum resection margin at laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2017;27(4):910–6.CrossRefPubMed Yormaz S, Yilmaz H, Ece I, et al. Midterm clinical outcomes of antrum resection margin at laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2017;27(4):910–6.CrossRefPubMed
20.
Zurück zum Zitat Sabench Pereferrer F, Molina Lopez A, Vives Espelta M, et al. Weight loss analysis according to different formulas after sleeve gastrectomy with or without antral preservation: a randomised study. Obes Surg. 2017;27(5):1254–60.CrossRefPubMed Sabench Pereferrer F, Molina Lopez A, Vives Espelta M, et al. Weight loss analysis according to different formulas after sleeve gastrectomy with or without antral preservation: a randomised study. Obes Surg. 2017;27(5):1254–60.CrossRefPubMed
21.
Zurück zum Zitat Peterli R, Wolnerhanssen BK, Vetter D, et al. Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss multicenter bypass or sleeve study (SM-BOSS). Ann Surg. 2017;265(3):466–73.CrossRefPubMed Peterli R, Wolnerhanssen BK, Vetter D, et al. Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss multicenter bypass or sleeve study (SM-BOSS). Ann Surg. 2017;265(3):466–73.CrossRefPubMed
22.
Zurück zum Zitat Chuffart E, Sodji M, Dalmay F, et al. Long-term results after sleeve gastrectomy for gastroesophageal reflux disease: a single-center French study. Obes Surg. 2017 Chuffart E, Sodji M, Dalmay F, et al. Long-term results after sleeve gastrectomy for gastroesophageal reflux disease: a single-center French study. Obes Surg. 2017
23.
Zurück zum Zitat Ece I, Yilmaz H, Acar F, et al. A new algorithm to reduce the incidence of gastroesophageal reflux symptoms after laparoscopic sleeve gastrectomy. Obes Surg. 2017;27(6):1460–5.CrossRefPubMed Ece I, Yilmaz H, Acar F, et al. A new algorithm to reduce the incidence of gastroesophageal reflux symptoms after laparoscopic sleeve gastrectomy. Obes Surg. 2017;27(6):1460–5.CrossRefPubMed
24.
Zurück zum Zitat Dakour Aridi H, Asali M, Fouani T, et al. Gastroesophageal reflux disease after laparoscopic sleeve gastrectomy with concomitant hiatal hernia repair: an unresolved question. Obes Surg. 2017. Dakour Aridi H, Asali M, Fouani T, et al. Gastroesophageal reflux disease after laparoscopic sleeve gastrectomy with concomitant hiatal hernia repair: an unresolved question. Obes Surg. 2017.
25.
Zurück zum Zitat Snyder B, Wilson E, Wilson T, et al. A randomized trial comparing reflux symptoms in sleeve gastrectomy patients with or without hiatal hernia repair. Surg Obes Relat Dis. 2016;12(9):1681–8.CrossRefPubMed Snyder B, Wilson E, Wilson T, et al. A randomized trial comparing reflux symptoms in sleeve gastrectomy patients with or without hiatal hernia repair. Surg Obes Relat Dis. 2016;12(9):1681–8.CrossRefPubMed
26.
Zurück zum Zitat Goitein D, Sakran N, Rayman S, et al. Barium swallow for hiatal hernia detection is unnecessary prior to primary sleeve gastrectomy. Surg Obes Relat Dis. 2017;13(2):138–42.CrossRefPubMed Goitein D, Sakran N, Rayman S, et al. Barium swallow for hiatal hernia detection is unnecessary prior to primary sleeve gastrectomy. Surg Obes Relat Dis. 2017;13(2):138–42.CrossRefPubMed
27.
Zurück zum Zitat Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74.CrossRefPubMed Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74.CrossRefPubMed
28.
29.
Zurück zum Zitat Nickel F, Schmidt L, Bruckner T, et al. Gastrointestinal quality of life improves significantly after sleeve gastrectomy and Roux-en-Y gastric bypass-a prospective cross-sectional study within a 2-year follow-up. Obes Surg. 2017;27(5):1292–7.CrossRefPubMed Nickel F, Schmidt L, Bruckner T, et al. Gastrointestinal quality of life improves significantly after sleeve gastrectomy and Roux-en-Y gastric bypass-a prospective cross-sectional study within a 2-year follow-up. Obes Surg. 2017;27(5):1292–7.CrossRefPubMed
30.
Zurück zum Zitat Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376(7):641–51.CrossRefPubMedPubMedCentral Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376(7):641–51.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Aminian A, Brethauer SA, Andalib A, et al. Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes. Ann Surg. 2016;264(4):674–81.CrossRefPubMed Aminian A, Brethauer SA, Andalib A, et al. Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes. Ann Surg. 2016;264(4):674–81.CrossRefPubMed
Metadaten
Titel
Update: 10 Years of Sleeve Gastrectomy—the First 103 Patients
verfasst von
Daniel M. Felsenreich
Lukas M. Ladinig
Philipp Beckerhinn
Christoph Sperker
Katrin Schwameis
Michael Krebs
Julia Jedamzik
Magdalena Eilenberg
Christoph Bichler
Gerhard Prager
Felix B. Langer
Publikationsdatum
25.07.2018
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 11/2018
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3399-1

Weitere Artikel der Ausgabe 11/2018

Obesity Surgery 11/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.